Broadcast date: 7 November 2024 — Speaker: Karen Ng
This webinar, hosted in collaboration between J A Kemp and DLRC, an award-winning regulatory consultancy, will explore the intellectual property challenges posed by the transparency requirements of the EU Clinical Trials Regulation. This complex issue calls for a strategic approach to patent protection in clinical trial-related inventions.
Presenters Karen Ng, Associate and European and UK Patent Attorney at J A Kemp, and James Biddlecombe, Business Transformation Manager & CTR Lead at DLRC Group will provide valuable insights into patent filing considerations, with a focus on the importance of early engagement and close coordination between legal and regulatory teams to maximise patent filing opportunities throughout the lifecycle of clinical trials.
This webinar is essential for professionals involved in patent protection, clinical trials, or regulatory affairs who are looking to optimise their approach in light of evolving regulations.
J A Kemp LLP acts for clients in the USA, Europe and globally, advising on UK and European patent practice and representing them before the European Patent Office, UKIPO and Unified Patent Court. We have in-depth expertise in a wide range of technologies, including Biotech and Life Sciences, Pharmaceuticals, Software and IT, Chemistry, Electronics and Engineering and many others. See our website to find out more.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
